New Key Statistics Module, Z-Score and F-Score
NAS:SRPT Key Ratios
Market Cap $ M | 12,531.96 |
Enterprise Value $ M | 12,854.24 |
P/E(ttm) | 331.45 |
PE Ratio without NRI | 174.22 |
Forward PE Ratio | 40.41 |
Price/Book | 13.04 |
Price/Sales | 9.04 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1,403.00 |
EPS (TTM) $ | 0.40 |
Beneish M-Score | -1.25 |
10-y EBITDA Growth Rate % | -7.80 |
5-y EBITDA Growth Rate % | 3.10 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 238.43 |
EV-to-EBITDA | 134.25 |
PEG | 56.20 |
Shares Outstanding M | 94.52 |
Net Margin (%) | 1.20 |
Operating Margin % | -6.76 |
Pre-tax Margin (%) | 2.43 |
Quick Ratio | 3.44 |
Current Ratio | 4.05 |
ROA % (ttm) | 0.54 |
ROE % (ttm) | 2.09 |
ROIC % (ttm) | -4.09 |
Dividend Yield % | -- |
Altman Z-Score | 2.68 |
SRPT Number of Guru Trades
SRPT Volume of Guru Trades
Gurus Latest Trades with NAS:SRPT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SRPT is held by these investors
Total 3
Sarepta Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SRPT
Total 0- 1